| scholarly article | Q13442814 |
| P356 | DOI | 10.3181/00379727-149-38929 |
| P953 | full work available at URL | http://www.ebmonline.org/cgi/content/abstract/149/4/930 |
| P698 | PubMed publication ID | 241081 |
| P2093 | author name string | C. Y. Pak | |
| L. H. Arnold | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | calcium oxalate | Q412399 |
| P304 | page(s) | 930-932 | |
| P577 | publication date | 1975-09-01 | |
| P1433 | published in | Proceedings of the Society for Experimental Biology and Medicine | Q45038026 |
| Experimental Biology and Medicine | Q15716535 | ||
| P1476 | title | Heterogeneous Nucleation of Calcium Oxalate by Seeds of Monosodium Urate | |
| P478 | volume | 149 |
| Q44214644 | Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis |
| Q57224947 | Calcium carbonate crystals promote calcium oxalate crystallization by heterogeneous or epitaxial nucleation: possible involvement in the control of urinary lithogenesis |
| Q35021693 | Clinical implications of physicochemistry of stone formation |
| Q34265048 | Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management |
| Q34662070 | Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts |
| Q50968152 | Correspondence between stone composition and urine supersaturation in nephrolithiasis. |
| Q41687422 | Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976 |
| Q38776852 | Differences in Urinary Stone Composition according to Body Habitus |
| Q40596772 | Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis |
| Q71341954 | Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate |
| Q38578034 | Epidemiology, Pathogenesis and diagnosis of calcium oxalate urolithiasis |
| Q35021705 | Hyperuricosuric calcium nephrolithiasis |
| Q43661660 | Hyperuricosuric calcium oxalate nephrolithiasis |
| Q48169824 | Hyperuricosuric calcium urolithiasis. |
| Q36635938 | Infrared spectrometry and Raman microprobe in the analysis of urinary calculi |
| Q39728243 | Inhibitors and promoters of stone formation |
| Q71227662 | Kidney stones |
| Q39137209 | Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate |
| Q37366264 | Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement |
| Q41877923 | Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites |
| Q71834893 | Natural urinary macromolecular inhibitors: attenuation of inhibitory activity by urate salts |
| Q46678964 | Nephrolithiasis in children |
| Q67455130 | Nucleation and growth of brushite and calcium oxalate in urine of stone-formers |
| Q36902337 | Pathogenesis of renal calculi |
| Q35021703 | Pathophysiology of uric acid nephrolithiasis |
| Q39728218 | Physicochemical aspects of urolithiasis |
| Q41582496 | Postmenopausal hormone and the risk of nephrolithiasis: A meta-analysis |
| Q35801600 | Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials |
| Q28830187 | Precipitation and Solubility of Calcium Hydrogenurate Hexahydrate |
| Q72516339 | Renal stone risk factors in patients with type IV renal tubular acidosis |
| Q66990005 | The Frequency of Renal Stones within Great Britain in a Gouty and Non-gouty Population |
| Q40905649 | The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription |
| Q41155349 | Urate and calcium stones--picking up a drop of mercury with one's fingers? |
| Q80748120 | Uric acid nephrolithiasis |
| Q71272799 | Uric acid saturation in calcium nephrolithiasis |
| Q71240523 | Urinary excretion of urate in patients with calcium oxalate stone disease |
| Q69352677 | Urolithiasis inhibitors and calculus nucleation |
| Q39728298 | Use of phosphates in patients with calcareous renal calculi |
Search more.